These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 34000462)

  • 1. Curcumin nanoformulations to combat aging-related diseases.
    Mahjoob M; Stochaj U
    Ageing Res Rev; 2021 Aug; 69():101364. PubMed ID: 34000462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Applications of Curcumin Nanoformulations.
    Yallapu MM; Nagesh PK; Jaggi M; Chauhan SC
    AAPS J; 2015 Nov; 17(6):1341-56. PubMed ID: 26335307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin targets in inflammation and cancer.
    Deguchi A
    Endocr Metab Immune Disord Drug Targets; 2015; 15(2):88-96. PubMed ID: 25772169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin-Based Nanoformulations: A Promising Adjuvant towards Cancer Treatment.
    Hafez Ghoran S; Calcaterra A; Abbasi M; Taktaz F; Nieselt K; Babaei E
    Molecules; 2022 Aug; 27(16):. PubMed ID: 36014474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanocurcumin: A Double-Edged Sword for Microcancers.
    Janjua KA; Shehzad A; Shahzad R; Islam SU; Islam MU
    Curr Pharm Des; 2020; 26(45):5783-5792. PubMed ID: 33213321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in curcumin nanoformulation for cancer therapy.
    Lee WH; Loo CY; Young PM; Traini D; Mason RS; Rohanizadeh R
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1183-201. PubMed ID: 24857605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Promising Therapeutic Avenues of Curcumin in Brain Diseases.
    Benameur T; Giacomucci G; Panaro MA; Ruggiero M; Trotta T; Monda V; Pizzolorusso I; Lofrumento DD; Porro C; Messina G
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review.
    Soleimani V; Sahebkar A; Hosseinzadeh H
    Phytother Res; 2018 Jun; 32(6):985-995. PubMed ID: 29480523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment.
    Naksuriya O; Okonogi S; Schiffelers RM; Hennink WE
    Biomaterials; 2014 Mar; 35(10):3365-83. PubMed ID: 24439402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nano Encapsulated Curcumin: And Its Potential for Biomedical Applications.
    Chen Y; Lu Y; Lee RJ; Xiang G
    Int J Nanomedicine; 2020; 15():3099-3120. PubMed ID: 32431504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyphenol nanoformulations for cancer therapy: experimental evidence and clinical perspective.
    Davatgaran-Taghipour Y; Masoomzadeh S; Farzaei MH; Bahramsoltani R; Karimi-Soureh Z; Rahimi R; Abdollahi M
    Int J Nanomedicine; 2017; 12():2689-2702. PubMed ID: 28435252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-microbial activity of curcumin nanoformulations: New trends and future perspectives.
    Sharifi S; Fathi N; Memar MY; Hosseiniyan Khatibi SM; Khalilov R; Negahdari R; Zununi Vahed S; Maleki Dizaj S
    Phytother Res; 2020 Aug; 34(8):1926-1946. PubMed ID: 32166813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multitargeting by turmeric, the golden spice: From kitchen to clinic.
    Gupta SC; Sung B; Kim JH; Prasad S; Li S; Aggarwal BB
    Mol Nutr Food Res; 2013 Sep; 57(9):1510-28. PubMed ID: 22887802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent progress in studying curcumin and its nano-preparations for cancer therapy.
    Liu J; Chen S; Lv L; Song L; Guo S; Huang S
    Curr Pharm Des; 2013; 19(11):1974-93. PubMed ID: 23116308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of rapamycin and curcumin on inflammation and oxidative stress in vitro and in vivo - in search of potential anti-epileptogenic strategies for temporal lobe epilepsy.
    Drion CM; van Scheppingen J; Arena A; Geijtenbeek KW; Kooijman L; van Vliet EA; Aronica E; Gorter JA
    J Neuroinflammation; 2018 Jul; 15(1):212. PubMed ID: 30037344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of curcumin and curcumin analogue effects in skin diseases: A narrative review.
    Panahi Y; Fazlolahzadeh O; Atkin SL; Majeed M; Butler AE; Johnston TP; Sahebkar A
    J Cell Physiol; 2019 Feb; 234(2):1165-1178. PubMed ID: 30073647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive review of the therapeutic potential of curcumin nanoformulations.
    Khezri K; Saeedi M; Mohammadamini H; Zakaryaei AS
    Phytother Res; 2021 Oct; 35(10):5527-5563. PubMed ID: 34131980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanocurcumin: A Promising Candidate for Therapeutic Applications.
    Karthikeyan A; Senthil N; Min T
    Front Pharmacol; 2020; 11():487. PubMed ID: 32425772
    [No Abstract]   [Full Text] [Related]  

  • 19. A review of therapeutic effects of curcumin.
    Noorafshan A; Ashkani-Esfahani S
    Curr Pharm Des; 2013; 19(11):2032-46. PubMed ID: 23116311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on Curcuma as a functional food in the control of cancer and inflammation.
    Schaffer M; Schaffer PM; Bar-Sela G
    Curr Opin Clin Nutr Metab Care; 2015 Nov; 18(6):605-11. PubMed ID: 26418821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.